Patent details

EP4531816 Title: PHARMACEUTICAL FORMULATIONS OF BICTEGRAVIR AND LENACAPAVIR

Basic Information

Publication number:
EP4531816
PCT Application Number:
US2024042251
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP247554777
PCT Publication Number:
WO2025038715
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATIONS OF BICTEGRAVIR AND LENACAPAVIR
French Title of Invention:
FORMULATIONS PHARMACEUTIQUES DE BICTÉGRAVIR ET DE LÉNACAPAVIR
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNGEN VON BICTEGRAVIR UND LENACAPAVIR
SPC Number:

Dates

Filing date:
14/08/2024
Grant date:
31/12/2025
EP Publication Date:
09/04/2025
PCT Publication Date:
20/02/2025
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/12/2025
EP B1 Publication Date:
31/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/08/2044
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/12/2025
 
 

Name:
Gilead Sciences, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
ARORA, Priyanka
Address:
United States (US)

2

Name:
FOGARTY, Julie A.
Address:
United States (US)

3

Name:
CLAMPFFER, Marina A.
Address:
United States (US)

Priority

1

Priority Number:
202363519675 P
Priority Date:
15/08/2023
Priority Country:
United States (US)

2

Priority Number:
23201068
Priority Date:
29/09/2023
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/24; A61K 9/20; A61K 31/4439; A61K 31/553; A61K 31/13; A61P 31/18;

Publication

European Patent Bulletin

1

Issue number:
202601
Publication date:
31/12/2025
Description:
Grant (B1)

2

Issue number:
202604
Publication date:
21/01/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
3
Annual Fee Amount:
33 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages